newsfilter
← Latest News
GlobeNewswire·

Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022

PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 28, 2022 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the first quarter ende